SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000045
Filing Date
2024-05-01
Accepted
2024-04-30 20:30:55
Documents
16
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 6-K a2024-05x01activitystateme.htm 6-K 22393
2 EX-99.1 exhibit991.htm EX-99.1 29384
3 EX-99.2 exhibit992.htm EX-99.2 8879
4 exhibit991001.jpg GRAPHIC 232005
5 exhibit991002.jpg GRAPHIC 257358
6 exhibit991003.jpg GRAPHIC 313860
7 exhibit991004.jpg GRAPHIC 53527
8 exhibit991005.jpg GRAPHIC 120622
9 exhibit991006.jpg GRAPHIC 127509
10 exhibit991007.jpg GRAPHIC 102241
11 exhibit991008.jpg GRAPHIC 110664
12 exhibit991009.jpg GRAPHIC 213643
13 exhibit991010.jpg GRAPHIC 162866
14 exhibit991011.jpg GRAPHIC 118747
15 exhibit992001.jpg GRAPHIC 271732
16 exhibit992002.jpg GRAPHIC 257465
  Complete submission text file 0001345099-24-000045.txt   3288644
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 24899543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)